2021

1. Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors

   Life, Vol. 11, Núm. 12

2. Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies

   Journal of Clinical Medicine, Vol. 10, Núm. 9